isoproterenol has been researched along with carbostyril in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (23.53) | 18.7374 |
| 1990's | 15 (44.12) | 18.2507 |
| 2000's | 7 (20.59) | 29.6817 |
| 2010's | 4 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endoh, M; Katano, Y | 1 |
| Belfrage, P; Calvo, J; Manganiello, VC; Smith, CJ; Vasta, V | 1 |
| Bast, A; Donnell, D; Voss, HP | 1 |
| Endoh, M; Hirano, K; Hosokawa, T; Norota, I; Satoh, H | 1 |
| Ikezawa, K; Kikkawa, H; Naito, K | 1 |
| Andersson, TL; Vinge, E | 1 |
| Andersson, KE; Lindgren, S | 1 |
| Crankshaw, D; Haslam, RJ; Maurice, DH | 1 |
| Andersson, KE; Andersson, TL; Lindgren, SH; Vinge, E | 1 |
| Malik, KU; Williams, JL | 1 |
| Church, MK | 1 |
| Barnes, PJ; Kioumis, I; Ukena, D | 1 |
| Arbabian, M; Busse, WW; Randlev, B; Ruoho, A | 1 |
| Andersson, KE; Belfrage, P; Degerman, E; Lindgren, S; Manganiello, VC | 1 |
| Baker, SP; Chida, Y; Ishizu, T; Kusiak, JW; Milecki, J; Pitha, J; Standifer, KM | 1 |
| Elks, ML; Manganiello, VC | 1 |
| Endoh, M; Satoh, K; Yamashita, S | 1 |
| Malik, KU; Schwartz, DD; Williams, JL | 1 |
| Isogaya, M; Kikkawa, H; Kurose, H; Nagao, T | 1 |
| Baker, SP; Dennis, DM; Deyrup, MD; Gelband, CH; Greco, PG; Otero, DH | 1 |
| Carey, GB; Finnegan, RB | 1 |
| Baker, SP; Deyrup, MD; Harrison, JK; Nowicki, ST; Otero, DH; Richards, NG | 1 |
| Iijima, T; Ishikawa, K; Kurata, S | 1 |
| Greenberg, AG; Kraemer, FB; Xue, B; Zemel, MB | 1 |
| Abzhalelov, BB; Bronnikov, GE; Dolgacheva, LP; Zhang, SJ; Zinchenko, VP | 1 |
| Advenier, C; Fairhurst, RA; Molimard, M; Naline, E; Trifilieff, A | 1 |
| Kaumann, A; Molenaar, P; Semmler, AB | 1 |
| Galindo-Tovar, A; Kaumann, AJ | 1 |
| Abi-Gerges, A; Conti, M; Fischmeister, R; Lechêne, P; Leroy, J; Mazet, JL; Nikolaev, VO; Richter, W; Vandecasteele, G | 1 |
| Galindo-Tovar, A; Kaumann, AJ; Vargas, ML | 1 |
| Arnoletti, E; Baragli, A; Ghè, C; Ghigo, E; Granata, R; Muccioli, G | 1 |
| Afzal, F; Aronsen, JM; Hussain, RI; Krobert, KA; Levy, FO; Osnes, JB; Sjaastad, I; Skomedal, T | 1 |
| Andersen, GØ; Ata, SH; Dahl, CP; Levy, FO; Orstavik, O; Osnes, JB; Qvigstad, E; Riise, J; Skomedal, T | 1 |
| Belacel-Ouari, M; Domergue-Dupont, V; Fischmeister, R; Hubert, F; Joubert, F; Leblais, V; Manoury, B; Mateo, P; Zhai, K | 1 |
1 review(s) available for isoproterenol and carbostyril
| Article | Year |
|---|---|
Reassessment of mast cell stabilizers in the treatment of respiratory disease.
Topics: Adrenal Cortex Hormones; Adult; Animals; Asthma; Child; Clinical Trials as Topic; Cromolyn Sodium; Histamine Antagonists; Humans; Isoproterenol; Mast Cells; Nedocromil; Quinolones; Rats; Theophylline | 1989 |
1 trial(s) available for isoproterenol and carbostyril
| Article | Year |
|---|---|
Reassessment of mast cell stabilizers in the treatment of respiratory disease.
Topics: Adrenal Cortex Hormones; Adult; Animals; Asthma; Child; Clinical Trials as Topic; Cromolyn Sodium; Histamine Antagonists; Humans; Isoproterenol; Mast Cells; Nedocromil; Quinolones; Rats; Theophylline | 1989 |
33 other study(ies) available for isoproterenol and carbostyril
| Article | Year |
|---|---|
Effects of a cardiotonic quinolinone derivative Y-20487 on the isoproterenol-induced positive inotropic action and cyclic AMP accumulation in rat ventricular myocardium: comparison with rolipram, Ro 20-1724, milrinone, and isobutylmethylxanthine.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Male; Milrinone; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridones; Pyrrolidinones; Quinolones; Rats; Rats, Wistar; Rolipram; Stimulation, Chemical; Thiadiazines | 1992 |
Insulin and isoproterenol induce phosphorylation of the particulate cyclic GMP-inhibited, low Km cyclic AMP phosphodiesterase (cGI PDE) in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adipose Tissue; Animals; Blotting, Western; Cell Differentiation; Cross Reactions; Insulin; Isoproterenol; Mice; Phosphorylation; Protein Kinases; Quinolones | 1992 |
Atypical molecular pharmacology of a new long-acting beta 2-adrenoceptor agonist, TA 2005.
Topics: Adrenergic beta-Agonists; Amphetamines; Animals; Binding, Competitive; Bronchodilator Agents; Cattle; GTP-Binding Proteins; Guinea Pigs; Hydroxyquinolines; Iodocyanopindolol; Isoproterenol; Magnesium; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Quinolones; Receptors, Adrenergic, beta; Trachea | 1992 |
Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Carbachol; Cardiotonic Agents; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Female; Isoproterenol; Male; Myocardial Contraction; Piperazines; Quinolones; Subcellular Fractions | 1991 |
Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amphetamines; Animals; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Guanosine Triphosphate; Guinea Pigs; Heart Ventricles; Histamine; Hydroxyquinolines; In Vitro Techniques; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Kinetics; Lung; Male; Membranes; Muscle Contraction; Muscle Relaxation; Pindolol; Procaterol; Quinolones; Radioligand Assay; Receptors, Adrenergic, beta; Trachea | 1991 |
Interactions between isoprenaline, sodium nitroprusside, and isozyme-selective phosphodiesterase inhibitors on ADP-induced aggregation and cyclic nucleotide levels in human platelets.
Topics: Cyclic AMP; Cyclic GMP; Drug Interactions; Humans; Isoproterenol; Nitroprusside; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinones; Quinolones | 1991 |
Comparison of the effects of milrinone and OPC 3911 with those of isoprenaline, forskolin and dibutyryl-cAMP in rat aorta.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Bucladesine; Calcium; Colforsin; In Vitro Techniques; Isoproterenol; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Potassium; Pyridones; Quinolones; Rats; Rats, Inbred Strains; Vasodilation | 1991 |
Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle.
Topics: Adenylyl Cyclases; Animals; Aorta; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Isoproterenol; Male; Molsidomine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroprusside; Quinolones; Rats; Rats, Inbred Strains; Vasodilator Agents | 1991 |
Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels.
Topics: Animals; Blood Platelets; Cyclic AMP; Guanfacine; Humans; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Milrinone; Muscle Tonus; Muscle, Smooth; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridones; Quinolones; Rats; Rats, Inbred Strains; Vinca Alkaloids | 1990 |
Inhibitory modulation by cAMP of isoproterenol-induced prostacyclin synthesis in rabbit heart.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 6-Ketoprostaglandin F1 alpha; Adenylyl Cyclase Inhibitors; Animals; Blood Pressure; Colforsin; Cyclic AMP; Epoprostenol; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardium; Phenylisopropyladenosine; Platelet Aggregation Inhibitors; Quinolones; Rabbits; Thionucleotides | 1989 |
Effect of nedocromil sodium on down-regulation of pulmonary beta-adrenoceptors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Guinea Pigs; Iodocyanopindolol; Isoproterenol; Lung; Male; Membranes; Nedocromil; Pindolol; Quinolones; Receptors, Adrenergic, beta | 1989 |
Effect of nedocromil sodium on the beta-adrenergic response of human polymorphonuclear leucocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Membrane; Cyclic AMP; Humans; In Vitro Techniques; Isoproterenol; Nedocromil; Neutrophils; Quinolones; Receptors, Adrenergic, beta | 1989 |
Relaxant effects of the selective phosphodiesterase inhibitors milrinone and OPC 3911 on isolated human mesenteric vessels.
Topics: Adult; Aged; Calcium Channel Blockers; Colforsin; Female; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Milrinone; Muscle, Smooth, Vascular; Norepinephrine; Ouabain; Phosphodiesterase Inhibitors; Potassium; Pyridones; Quinolones; Splanchnic Circulation; Vasodilator Agents | 1989 |
Carbostyril derivatives having potent beta-adrenergic agonist properties.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Hydroxyquinolines; Isoproterenol; Kinetics; Membranes; Quinolones; Receptors, Adrenergic, beta; Reticulocytes | 1987 |
Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adipose Tissue; Animals; Enzyme Activation; Insulin; Isoproterenol; Lipolysis; Quinolines; Quinolones; Rats | 1985 |
Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Dogs; Female; Heart Rate; Isoproterenol; Male; Myocardial Contraction; Myocardium; Papillary Muscles; Phosphodiesterase Inhibitors; Quinolines; Quinolones; Rabbits; Theophylline | 1980 |
Contribution of calcium to isoproterenol-stimulated lipolysis in the isolated perfused rabbit heart.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcium; Calcium Channel Blockers; Cyclic AMP; Diltiazem; Gallic Acid; Glycerol; Heart; In Vitro Techniques; Isoproterenol; Lipolysis; Male; Myocardium; Quinolones; Rabbits | 1993 |
The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Alanine; Amphetamines; Animals; Binding Sites; Cell Membrane; COS Cells; Hydroxyquinolines; Isoproterenol; Kinetics; Mutagenesis, Site-Directed; Quinolones; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Serine; Substrate Specificity | 1998 |
Irreversible binding of a carbostyril-based agonist and antagonist to the beta-adrenoceptor in DDT1 MF-2 cells and rat aorta.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Cell Line; Hydroxyquinolines; In Vitro Techniques; Isoproterenol; Male; Quinolones; Rats | 1998 |
Characterization of cyclic AMP efflux from swine adipocytes in vitro.
Topics: Adipocytes; Adrenergic beta-Agonists; Animals; Antimycin A; Cells, Cultured; Colforsin; Cyclic AMP; Isoproterenol; Probenecid; Quinolones; Swine; Swine, Miniature; Xanthines | 1998 |
Structure-affinity profile of 8-hydroxycarbostyril-based agonists that dissociate slowly from the beta2-adrenoceptor.
Topics: Adrenergic beta-Agonists; Catechols; Cell Culture Techniques; Cell Line; Cyclic AMP; Hydroxyquinolines; Isoproterenol; Ligands; Linear Models; Phosphoric Diester Hydrolases; Quinolones; Receptors, Adrenergic, beta-2; Structure-Activity Relationship; Time Factors | 1999 |
Enhancement by arginine vasopressin of the L-type Ca2+ current in guinea pig ventricular myocytes.
Topics: Animals; Arginine Vasopressin; Calcium; Calcium Channels; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Guinea Pigs; Heart; Isoproterenol; Piperidines; Potassium Channels; Quinolones | 1999 |
Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 8-Bromo Cyclic Adenosine Monophosphate; Adipocytes; Androstadienes; Bucladesine; Calcium; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Humans; Insulin; Isoproterenol; Lipolysis; Phosphodiesterase Inhibitors; Phosphorylation; Potassium Chloride; Quinolones; Sterol Esterase; Wortmannin; Xanthines | 2001 |
Norepinephrine induces slow calcium signalling in murine brown preadipocytes through the beta-adrenoceptor/cAMP/protein kinase A pathway.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adipocytes; Adipose Tissue, Brown; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Calcium Signaling; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Isoproterenol; Isoquinolines; Male; Mice; Mice, Inbred Strains; Norepinephrine; Phosphodiesterase Inhibitors; Quinolones; Receptors, Adrenergic, beta; Sulfonamides; Thapsigargin | 2003 |
Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi.
Topics: Adrenergic beta-Agonists; Airway Resistance; Albuterol; Bronchi; Bronchoconstriction; Dose-Response Relationship, Drug; Electric Stimulation; Ethanolamines; Female; Formoterol Fumarate; Humans; In Vitro Techniques; Indans; Isoproterenol; Male; Middle Aged; Muscle, Smooth; Quinolones; Salmeterol Xinafoate; Treatment Outcome | 2007 |
The effects of both noradrenaline and CGP12177, mediated through human beta1 -adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Aged; Animals; Atrial Appendage; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Synergism; Female; Humans; Isometric Contraction; Isoproterenol; Male; Middle Aged; Norepinephrine; Phosphodiesterase Inhibitors; Propanolamines; Quinolones; Receptors, Adrenergic, beta-1; Rolipram; Signal Transduction | 2007 |
Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Epinephrine; Female; Heart Atria; Heart Rate; Heart Ventricles; Imidazoles; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Propanolamines; Quinolones; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Rolipram; Sinoatrial Node; Tachycardia, Sinus; Tachycardia, Ventricular | 2008 |
Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adrenergic beta-Agonists; Animals; Biosensing Techniques; Calcium Channels, L-Type; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide-Gated Cation Channels; Cytosol; Dose-Response Relationship, Drug; Enzyme Activation; Fluorescence Resonance Energy Transfer; Guanine Nucleotide Exchange Factors; Heart Ventricles; Isoproterenol; Kinetics; Male; Membrane Potentials; Microscopy, Fluorescence; Myocardial Contraction; Myocytes, Cardiac; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Phosphorylation; Quinolones; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Sarcolemma; Signal Transduction; Transfection | 2008 |
Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (-)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Arrhythmia, Sinus; Atrial Function, Left; Atrial Function, Right; Bradycardia; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Drug Partial Agonism; Female; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Propanolamines; Quinolones; Rats; Rats, Sprague-Dawley; Rolipram; Stimulation, Chemical; Tachycardia | 2009 |
Acylated and unacylated ghrelin attenuate isoproterenol-induced lipolysis in isolated rat visceral adipocytes through activation of phosphoinositide 3-kinase γ and phosphodiesterase 3B.
Topics: Acylation; Adipocytes; Adrenergic beta-Agonists; Animals; Benzimidazoles; Blotting, Western; Cells, Cultured; Class Ib Phosphatidylinositol 3-Kinase; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Dose-Response Relationship, Drug; Drug Interactions; Ghrelin; Glycerol; Intra-Abdominal Fat; Isoproterenol; Lipolysis; Male; Phosphodiesterase Inhibitors; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolones; Quinoxalines; Rats; Rats, Wistar; Thiazolidinediones | 2011 |
The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Carbachol; Cardiotonic Agents; GTP-Binding Protein alpha Subunits, Gi-Go; Heart Failure; Heart Ventricles; In Vitro Techniques; Isoproterenol; Male; Muscarinic Agonists; Myocardial Contraction; Myocardial Infarction; Pertussis Toxin; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Quinolones; Rats; Rats, Wistar; Rolipram; Ventricular Pressure | 2013 |
Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiotonic Agents; Heart; Heart Failure; Humans; Hydrazones; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Contraction; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Pyridazines; Quinolines; Quinolones; Rats, Wistar; Rolipram; Simendan; Thiadiazines | 2014 |
Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4.
Topics: Adrenergic beta-Agonists; Animals; Aorta, Thoracic; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Dinoprost; Endothelium, Vascular; Gene Expression; Heart Failure; In Vitro Techniques; Isoproterenol; Male; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Quinolones; Rats, Wistar; RNA, Messenger; Vasoconstriction | 2014 |